BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8856309)

  • 1. Epidemiology and clinical management of endometrial carcinoma in the Republic of Georgia in the last 30 years.
    Charkviani T; Charkviani L; Chitiashvili R; Glonti L
    Eur J Gynaecol Oncol; 1996; 17(4):292-5. PubMed ID: 8856309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial cancer.
    Sorosky JI
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):436-47. PubMed ID: 18238985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment.
    Roland PY; Kelly FJ; Kulwicki CY; Blitzer P; Curcio M; Orr JW
    Gynecol Oncol; 2004 Apr; 93(1):125-30. PubMed ID: 15047225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy.
    Kim YB; Niloff JM
    Obstet Gynecol; 1993 Aug; 82(2):175-80. PubMed ID: 8336860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal variants of treatment of stage I endometrial carcinoma and its choice.
    Charkviani TL
    Eur J Gynaecol Oncol; 1993; 14(2):154-9. PubMed ID: 8500500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
    Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The surgical and radiotherapy treatment of endometrial adenocarcinoma. A retrospective analysis of 128 patients].
    Sacco M; Rotta P; Rampino M
    Radiol Med; 1991 Nov; 82(5):658-63. PubMed ID: 1780466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
    Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
    J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
    Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
    Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary radiotherapy of laryngeal carcinoma. An analysis of the therapeutic results and of the the relapse behavior in 283 patients].
    Rübe C; Micke O; Grevers G; Rohloff R; Kaufmann H; Busch M; Willich N
    Strahlenther Onkol; 1997 Feb; 173(2):83-90. PubMed ID: 9072844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical vs. clinical staging of endometrial carcinoma. The impact on treatment modification, morbidity and survival.
    Hourvitz A; Menczer J; Chetrit A; Modan B
    Eur J Gynaecol Oncol; 1995; 16(5):357-62. PubMed ID: 8549600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
    Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does surgical staging of clinical Stage I endometrial carcinoma significantly alter adjuvant management?
    Burke C; Hickey K
    J Obstet Gynaecol; 2004 Apr; 24(3):289-91. PubMed ID: 15203630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
    Scarfone G; Secomandi R; Parazzini F; Viganò R; Mangili G; Frigerio L; Villa A; Tateo S; Ricci E; Bolis G
    Arch Gynecol Obstet; 2013 Feb; 287(2):351-6. PubMed ID: 23100038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery and postoperative radiation therapy in FIGO Stage IIIC endometrial carcinoma.
    Mundt AJ; Murphy KT; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1154-60. PubMed ID: 11483324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical stage III endometrial cancer: analysis of treatment outcomes, prognostic factors and failure patterns.
    Ayhan A; Taskiran C; Celik C; Aksu T; Yuce K
    Eur J Gynaecol Oncol; 2002; 23(6):553-6. PubMed ID: 12556104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined treatment and prognostic factors for stage III and IV endometrial carcinoma].
    Ren YL; Wang HY; Shi DR; Yang WT; Sun Z; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jul; 43(7):523-7. PubMed ID: 19080517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.